首页 | 本学科首页   官方微博 | 高级检索  
检索        

哌拉西林/他唑巴坦治疗30例自发性腹膜炎的临床观察
引用本文:杨亦德.哌拉西林/他唑巴坦治疗30例自发性腹膜炎的临床观察[J].江西医学院学报,2006,46(3):132-133.
作者姓名:杨亦德
作者单位:台州市立医院感染科,浙江台州318000
摘    要:目的观察哌拉西林/他唑巴坦(PIP/TAZ)治疗肝硬化合并自发性腹膜炎(SBP)的临床疗效和安全性。方法30侧患者在护肝、利尿、支持、对症治疗的基础上给予哌拉西林/他唑巴坦4.5g,q8h,静脉滴注;主要观察治疗前后患者的临床症状、体征、腹水常规以及药物的不良反应等。结果用哌拉西林/他唑巴坦治疗肝硬化合并自发性腹膜炎的患者.总有效率可达83.33%,不良反应发生率6.67%。结论表明哌拉西林/他唑巴坦可以有效地控制自发性腹膜炎患者的细菌感染,可以作为经验性治疗SBP的首选药物。

关 键 词:抗生素  自发性腹膜炎  肝硬化
文章编号:1000-2294(2006)03-0132-02
收稿时间:04 7 2006 12:00AM
修稿时间:2006年4月7日

The Treatment of 30 patients with Spontaneous Bacterial Peritonitis by Piperacillin/Tazobactam
YANG Yi-de.The Treatment of 30 patients with Spontaneous Bacterial Peritonitis by Piperacillin/Tazobactam[J].Acta Academiae Medicinae Jiangxi,2006,46(3):132-133.
Authors:YANG Yi-de
Institution:Taizhou Municipal Hospital of Zhejiang Province, Taizhou Zhejiang 318000,China
Abstract:Objective To evaluate the efficiency and safety of piperacillin/tazobactam in the treatment of cirrhotic patients with spontaneous bacterial peritonitis. Methods Thirty patients were given piperacillin/tazobactam at 4.5 g q8h in addition to the basis of comprehensive treatment consisting of protecting liver, diuresis, and related support. Clinical symptom, physical signs, alteration of ascites and adverse reaction etc. were observed and compared with pre-treatment. Results Clinical total effective rate was up to 83.33%.when conducting piperacillin/tazobactam in the treatment of cirrhotic patients with spontaneous bacterial peritonitis, while the occurring rate of adverse reaction merely was 6.67%. Conclusion Piperacillin/tazobactam is effective and safe in the treatment of cirrhotic patients with spontaneous bacterial peritonitis.
Keywords:antibiotic  spontaneous bacterial peritonitis  cirrhosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号